Tocilizumab for severe COVID-19 pneumonia
- Resource Type
- Correspondence
- Authors
- Arcidiacono, G; Benfaremo, D; Bettini, S; Bonora, BM; Bucca, G; Cattelan, A; Cerruti, L; Dalbeni, A; Framba, V; Gabrielli, A; Gambino, CG; Ghirardini, F; Gnudi, U; Luchetti, MM; Mantovani, A; Mareso, S; Marini, M; Martini, A; Mattioli, M; Mucci, L; Perna, GP; Presotto, F; Sensi, C; Serra, R; Soliani, F; Stupia, R; Vettore, E; Zoncapè, M; Piano, Salvatore; Vettor, Roberto; Angeli, Paolo
- Source
- In The Lancet Rheumatology November 2020 2(11):e659-e660
- Subject
- Analysis and Interpretation
Correspondence
- Language
- ISSN
- 2665-9913